Innovaccer

Innovaccer is a leading player in the healthcare industry, providing a comprehensive data platform for value-based care. Founded in 2014 and headquartered in the United States, the company has garnered significant attention for its innovative solutions, with its recent achievement being the $150.00M Series E investment round on 15 December 2021. This latest funding, led by a consortium of prominent investors including B Capital Group, M12, Tiger Global Management, Steadview Capital, Dragoneer Investment Group, OMERS Growth Equity, Schonfeld Strategic Advisors, Whale Rock Capital Management, Avidity Partners and Mubadala Capital Ventures, speaks volumes about the confidence and support Innovaccer has garnered. Innovaccer's platform is designed to unify patient data across systems and care settings, enhancing the capabilities of healthcare organizations by offering modern, scalable applications that drive improvements in clinical, financial, operational, and experiential outcomes. The company's EHR-agnostic solutions have been successfully implemented across more than 1,600 hospitals and clinics in the US, playing a pivotal role in facilitating care delivery transformation for over 96,000 clinicians. Furthermore, Innovaccer has played a significant role in enabling providers to collaborate effectively with payers and life sciences companies, leading to the unification of health records for more than 54 million people and generating over $1 billion in cumulative cost savings. The remarkable achievements of Innovaccer have been recognized and acknowledged, as evidenced by its platform's top ratings. The Innovaccer platform has been acclaimed as the #1 rated Best-in-KLAS data and analytics platform by KLAS, as well as the #1 rated population health technology platform by Black Book. These accolades are a testament to Innovaccer's dedication to driving innovation and excellence in the healthcare analytics industry. For more information, please visit innovaccer.com.